Commercial stage biotech company pioneering prescription digital therapeutics. Click develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs to deliver safe and effective digital treatments to patients in need
First precision medicine company to personalize medication treatment by combining advanced methods to predict the right drug and right dose for multiple medical conditions with direct measurement of medications in a patient’s circulation to determine drug-drug interactions, and patient drug adherence.
Late stage medical technology company developing a non-invasive, early lung cancer detection technology for high-risk patients using 3D cell imaging, and a patented AI-powered cancer detection process.
Early clinical-stage, biotechnology company developing novel oncology therapeutics
Precision Medicine company with a first-in-class test to identify early-stage breast cancer patients with poor prognosis that may respond to FDA-approved antifibrotic therapy to prevent bone metastasis